#33 - Marcio Souza, CEO of Praxis Precision Medicines
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines.
What you'll get out of this episode:
- Discussion on innovative CNS drug development on BioBreakthroughs podcast.
- Learn about Praxis' genetics-inspired approach to tackling complex brain diseases.
- Souza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE studies.
- Discover Praxis Precision Medicines' future prospects and their commitment to revolutionizing patient care in the CNS field.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/marcio-souza-2b02837/
Company LinkedIn: https://www.linkedin.com/company/praxis-precision-medicines-inc/
Website: https://praxismedicines.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/